The Role of HDL and HDL Mimetic Peptides as Potential Therapeutics for Alzheimer’s Disease

Por Chernick, Dustin, Zhong, Rui, Li, Ling
Publicado no Biomolecules (2020)

HDL and Cognition in Neurodegenerative Disorders

Por Hottman, David A., Chernick, Dustin, Cheng, Shaowu, Wang, Zhe, Li, Ling
Publicado no Neurobiol Dis (2014)

Peripheral Versus Central Nervous System APOE in Alzheimer’s Disease: Interplay across the Blood-Brain Barrier

Por Chernick, Dustin, Ortiz-Valle, Stephanie, Jeong, Angela, Qu, Wenhui, Li, Ling
Publicado no Neurosci Lett (2019)

Amantadine ER (Gocovri(®)) Significantly Increases ON Time Without Any Dyskinesia: Pooled Analyses From Pivotal Trials in Parkinson's Disease

Por Hauser, Robert A., Walsh, Ryan R., Pahwa, Rajesh, Chernick, Dustin, Formella, Andrea E.
Publicado no Front Neurol (2021)

HDL Mimetic Peptide 4F Mitigates Aβ-Induced Inhibition of ApoE Secretion and Lipidation in Primary Astrocytes and Microglia

Por Chernick, Dustin, Ortiz-Valle, Stephanie, Jeong, Angela, Swaminathan, Suresh Kumar, Kandimalla, Karunya K., Rebeck, G. William, Li, Ling
Publicado no J Neurochem (2018)

EASE LID 2: A 2-Year Open-Label Trial of Gocovri (Amantadine) Extended Release for Dyskinesia in Parkinson’s Disease

Por Tanner, Caroline M., Pahwa, Rajesh, Hauser, Robert A., Oertel, Wolfgang H., Isaacson, Stuart H., Jankovic, Joseph, Johnson, Reed, Chernick, Dustin, Hubble, Jean
Publicado no J Parkinsons Dis (2020)

Metabolic Labeling with an Alkyne-modified Isoprenoid Analog Facilitates Imaging and Quantification of the Prenylome in Cells

Por Palsuledesai, Charuta C., Ochocki, Joshua D., Kuhns, Michelle M., Wang, Yen-Chih, Warmka, Janel K., Chernick, Dustin S., Wattenberg, Elizabeth V., Li, Ling, Arriaga, Edgar A., Distefano, Mark D.
Publicado no ACS Chem Biol (2016)